Leslie W. Chinn

Very important pharmacogene summary

Laura M. Hodges, Svetlana Markova, Leslie W. Chinn et al. · Pharmacogenetics and Genomics · 2010 · 433 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +1

Evolutionary Conservation of Vertebrate Blood–Brain Barrier Chemoprotective Mechanisms in<i>Drosophila</i>

Fahima Mayer, Nasima Mayer, Leslie W. Chinn et al. · Journal of Neuroscience · 2009 · 190 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Efficacy, Safety, and Pharmacodynamic Effects of the Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib (GDC‐0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial

David Isenberg, Richard Furie, Nicholas S. Jones et al. · Arthritis & Rheumatology · 2021 · 134 citations

Medicine, Pharmacology, Pharmacotherapy +16

Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial

Martin Metz, Gordon Sussman, Rémi Gagnon et al. · Nature Medicine · 2021 · 134 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +16

Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double‐Blind, Phase <scp>II</scp> Trial

Stanley Cohen, Katie Tuckwell, Tamiko R. Katsumoto et al. · Arthritis & Rheumatology · 2020 · 118 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17